Eugia Pharma Specialities Limited Irinotecan Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Irinotecan Export Records India — #3 Exporter, 88 Shipments, $4.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irinotecan

India Pharmaceutical Trade Intelligence

$41.1M164 Suppliers111 CountriesHS 30049049

ExportsIndia → GERMANY19.7%India → POLAND10.7%

ImportsAUSTRALIA → India$78.4M FRANCE → India$17.9M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: FRESENIUS KABI

Eugia Pharma Specialities Limited — Irinotecan Exporter #3 | $4.4M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Irinotecan Exporter Profile

Indian Pharmaceutical Exporter · #3 for Irinotecan · $4.4M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #3 Indian exporter of Irinotecan with $4.4M in export value and 88 verified shipments. Eugia Pharma Specialities Limited holds a 10.7% market share in Irinotecan exports across 10 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Irinotecan Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Irinotecan export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Irinotecan?

Country	Value	Shipments	Share
UNITED STATES	$1.2M	33	40.9%
CANADA	$783.7K	18	25.8%
MALTA	$485.7K	17	16.0%
KAZAKISTAN	$173.1K	6	5.7%
MEXICO

Who Are the Top Buyers of Irinotecan from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
EUGIA PHARMA INC	CANADA	$625.9K	14
EUGIA US LLC	UNITED STATES	$488.7K	13
EUGIA US LLC,	UNITED STATES	$442.8K	12
AUROLOGISTICS LLC (AUROMEDICS PHARM	UNITED STATES	$265.9K	8
EUGIA PHARMA (MALTA) LTD,	MALTA	$264.4K	9
EUGIA PHARMA MALTA LTD	MALTA	$152.0K	6
AROVINDA FARMACEUTICA. S.A	MEXICO	$134.0K	3
EUGIA PHARMA INC,	CANADA	$107.8K	3
AUROMEDICS PHARMA, LLC,	UNITED STATES	$100.0K	2
TOO ROGERS PHARMA	KAZAKISTAN	$94.6K	4

Eugia Pharma Specialities Limited supplies Irinotecan to 19 buyers globally. The largest buyer is EUGIA PHARMA INC (CANADA), followed by EUGIA US LLC (UNITED STATES) and EUGIA US LLC, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irinotecan Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
IRINOTECAN HYDROCHLORIDE INJECTION USP,	$586.7K	19
IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR	$182.9K	5
IRINOTECAN HYDROCHLORIDE INJECTION USP100MG/5 ML(CETABINDO)VLS	$134.0K	3
IRINOTECAN HYDROCHLORIDE INJECTION USP500MG/25ML (IRINOTECAN HYDROCHLORIDE INJECTION 20MG/ML(500MG/25ML)-CANADA-EUGIA)	$100.0K	2
IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION 20 MG/ML Irinotecan Hydrochloride 20mg/mL concentrate for solution fo	$98.2K	2
IRINOTECAN HYDROCHLORIDE INJECTION USP100 MG/5 ML (IRNIZET 100) (5074 PACK)	$60.9K	2
IRINOTECAN HYDROCHLORIDE INJECTION USP 300 MG 15 ML 20MG ML 4093X1 S	$50.0K	1
IRINOTECAN HYDROCHLORIDE INJECTION USP,3	$50.0K	1
IRINOTECAN HYDROCHLORIDE INJECTION USP300MG/15 MLIRINOTECAN HYDROCHLORIDE INJECTION USP300 MG/15 ML20MG/ML - US	$50.0K	1
IRINOTECAN HYDROCHLORIDE INJECTION USP,300MG/15ML IRINOTECAN HYDROCHLORIDE INJECTION USP, 300 MG/15 ML 20MG/ML - US	$50.0K	1

Eugia Pharma Specialities Limited exports 59 distinct Irinotecan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRINOTECAN HYDROCHLORIDE INJECTION USP, with 19 shipments worth $586.7K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Irinotecan Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED	$14.7M	1,099	20	$13.4K
2	FRESENIUS KABI ONCOLOGY LIMITED	$10.4M	670	24	$15.6K
3	EUGIA PHARMA SPECIALITIES LIMITED ★	$4.4M	88	10	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.1M	92	3	$33.8K
5	VENUS REMEDIES LIMITED	$1.3M	110	16	$11.6K

Eugia Pharma Specialities Limited ranks #3 among 164 Indian Irinotecan exporters. Average shipment value of $50.0K compared to the market average of $228.7K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and FRESENIUS KABI ONCOLOGY LIMITED.

Which Indian Ports Ship Irinotecan Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	300	10.3%
SAHAR AIR	296	10.2%
AHEMDABAD AIR ACC (INAMD4)	252	8.7%
MUNDRA SEA (INMUN1)	217	7.5%
SAHAR AIR CARGO ACC (INBOM4)	207	7.1%
DELHI AIR	205	7.1%
AHEMDABAD AIR	205	7.1%
MUNDRA SEA	152	5.2%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Irinotecan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irinotecan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 88 individual customs records matching Eugia Pharma Specialities Limited exporting Irinotecan, covering 59 formulations to 11 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 111+ countries, 495+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irinotecan

Irinotecan

Eugia Pharma Specialities Limited — Irinotecan Exporter Profile

Eugia Pharma Specialities Limited — Irinotecan Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Irinotecan?

Who Are the Top Buyers of Irinotecan from Eugia Pharma Specialities Limited?

What Is India's Total Irinotecan Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Irinotecan Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Irinotecan Exporters?

What Irinotecan Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Irinotecan to Key Markets

United States — FDA

Canada — HC

How Does Eugia Pharma Specialities Limited Compare to Nearest Irinotecan Exporters?

Which Indian Ports Ship Irinotecan Exports?

What Other Oncology Products Does Eugia Pharma Specialities Limited Export?

Irinotecan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Irinotecan Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irinotecan Export Data from Eugia Pharma Specialities Limited

Irinotecan Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source